PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Cotswold Distillery creates quality craft sprits. Their distillery is vote the top attraction according to trip advisor; they have 3 tours a day, 7 days a week and approximately 30,000 visitors every year. They have created a single malt whiskey and premium gins both have won awards internationally.
They are looking for funding to build brand awareness and long term growth.
days to go:
Expired
investment:
£2,839,460
Candy Kitten are a confectionary company that were built to modernise the confectionary industry by introducing new flavours and a higher quality product than those currently available.
days to go:
Expired
investment:
£161,016
Charbrew is an all natural ice tea which contains no refined sugars (only natural fruit sugars), essential b-vitamins and real tea. Each bottle of Charbrew is under 85 calories and contains less sugar than Coconut Water by Vita Coco. Charbrew is already distributed internationally with the recently launched international branches: Charbrew Australia and Charbrew USA.
days to go:
Expired
investment:
£126,370
To help reduce wasted food, Daily Dose source 'wonky' fruit and veg for their organic cold-pressed juices. They sell over 40,000 drinks on average every month and supply their products to more than 150 stockists, as well as launching a café in 2017. They are currently researching methods to extend the shelf life of their juices. Daily Dose moved from a 500sq ft. to a 2500sq ft. facility in 2016, now they are raising funds to triple the size of their site.
days to go:
Expired
investment:
£305,740
Pedal Me (PM) uses proprietary electric cargo bikes in combination with trained employees to provide a fast, clean on-demand service to help move both people and goods around London. It argues that it trains its personnel based upon the curriculum of the City and Guilds of London Institute creating skilled riders who can carry passenger payloads up to 150 kilos, cargo payloads up to 150 kilos, and trailer payloads up to 300 kilos, respectively, on their bikes, covering distances at a speed motor vehicles cannot match. PM has grown to 50 personnel and 52 bikes since its founding in 2017. It has featured in global print media such as BBC News, Financial Times, and Volkskrant. PM also earned revenue worth £657,000 in February 2021 despite the COVID-19 crisis. It will use the investment to scale and find efficient ways to continue its growth.
days to go:
Expired
investment:
£600,000
The GP Service is a web and application-based platform that provides private consultations for patients across the UK. The aim is to provide a safe and easy journey for individuals who are looking for private medical treatment at their convenience and at an affordable cost. They have established a connection with over 1600 pharmacies across the UK. They have an excellent 5-star trust pilot rating and also are 1st Private Online Provider which has access to NHS Medical Records. With the proceeds, the company will scale the enterprise offering, increase brand awareness and also launch additional revenue opportunities.
days to go:
Expired
investment:
£907,540
